Autoreactive Memory CD4+ T Lymphocytes That Mediate Chronic Uveitis Reside in the Bone Marrow through STAT3-Dependent Mechanisms
- 15 September 2011
- journal article
- Published by The American Association of Immunologists
- Vol. 187 (6), 3338-3346
- https://doi.org/10.4049/jimmunol.1004019
Abstract
Organ-specific autoimmune diseases are usually characterized by repeated cycles of remission and recurrent inflammation. However, where the autoreactive memory T cells reside in between episodes of recurrent inflammation is largely unknown. In this study, we have established a mouse model of chronic uveitis characterized by progressive photoreceptor cell loss, retinal degeneration, focal retinitis, retinal vasculitis, multifocal choroiditis, and choroidal neovascularization, providing for the first time to our knowledge a useful model for studying long-term pathological consequences of chronic inflammation of the neuroretina. We show that several months after inception of acute uveitis, autoreactive memory T cells specific to retinal autoantigen, interphotoreceptor retinoid-binding protein (IRBP), relocated to bone marrow (BM). The IRBP-specific memory T cells (IL-7RαHighLy6CHighCD4+) resided in BM in resting state but upon restimulation converted to IL-17/IFN-γ–expressing effectors (IL-7RαLowLy6CLowCD4+) that mediated uveitis. We further show that T cells from STAT3-deficient (CD4-STAT3KO) mice are defective in α4β1 and osteopontin expression, defects that correlated with inability of IRBP-specific memory CD4-STAT3KO T cells to traffic into BM. We adoptively transferred uveitis to naive mice using BM cells from wild-type mice with chronic uveitis but not BM cells from CD4-STAT3KO, providing direct evidence that memory T cells that mediate uveitis reside in BM and that STAT3-dependent mechanism may be required for migration into and retention of memory T cells in BM. Identifying BM as a survival niche for T cells that cause uveitis suggests that BM stromal cells that provide survival signals to autoreactive memory T cells and STAT3-dependent mechanisms that mediate their relocation into BM are attractive therapeutic targets that can be exploited to selectively deplete memory T cells that drive chronic inflammation.Keywords
This publication has 36 references indexed in Scilit:
- Reproducibility of Spectral-Domain Optical Coherence Tomography Total Retinal Thickness Measurements in MiceInvestigative Opthalmology & Visual Science, 2010
- Control of α4β7 Integrin Expression and CD4 T Cell Homing by the β1 Integrin SubunitPublished by The American Association of Immunologists ,2010
- Diversity in T Cell Memory: An Embarrassment of RichesImmunity, 2009
- Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector categoryThe Journal of Experimental Medicine, 2008
- New perspectives on effector mechanisms in uveitisSeminars in Immunopathology, 2008
- TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1Nature Medicine, 2007
- Fibrosis and diseases of the eyeJCI Insight, 2007
- Autoimmune arthritis associated with mutated interleukin (IL)-6 receptor gp130 is driven by STAT3/IL-7–dependent homeostatic proliferation of CD4+ T cellsThe Journal of Experimental Medicine, 2006
- Direct access to CD4+ T cells specific for defined antigens according to CD154 expressionNature Medicine, 2005
- Administration of a Peptide Inhibitor of α4-Integrin Inhibits the Development of Experimental Autoimmune UveitisPublished by Association for Research in Vision and Ophthalmology (ARVO) ,2005